Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Asthma

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Asthma in 2 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, X1
Liu, C1
Wu, L1
Zhu, S1
Crotty Alexander, LE1
Akong-Moore, K1
Feldstein, S1
Johansson, P1
Nguyen, A1
McEachern, EK1
Nicatia, S1
Cowburn, AS1
Olson, J1
Cho, JY1
Isaacs, H1
Johnson, RS1
Broide, DH1
Nizet, V1

Other Studies

2 other studies available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Asthma

ArticleYear
Potent ameliorating effect of Hypoxia-inducible factor 1α (HIF-1α) antagonist YC-1 on combined allergic rhinitis and asthma syndrome (CARAS) in Rats.
    European journal of pharmacology, 2016, Oct-05, Volume: 788

    Topics: Animals; Anti-Allergic Agents; Asthma; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha

2016
Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function.
    Journal of molecular medicine (Berlin, Germany), 2013, Volume: 91, Issue:5

    Topics: Airway Resistance; Animals; Asthma; Basic Helix-Loop-Helix Transcription Factors; Bronchoalveolar La

2013